Published in 2021 on Journal of Alzheimer's Disease, one study confirmed that a course of high doses of CBD of at least two weeks can restore the function of two proteins, which are essential for reduce the symptoms of Alzheimer's.
In particular of familial Alzheimer's: one version hereditary of the disease that affects approximately two or more people belonging to the same household, manifesting its first symptoms in people between 30 and 40 years of age.
CBD and Alzheimer's: it could mitigate its symptoms
“There is a desperate need for innovative therapeutic modalities to improve outcomes of patients with AD. In this study, we tested whether cannabidiol (CBD) improves outcomes in a translational model of familial AD,” the researchers explain.
In the study carried out on mice, researchers found that CBD improved the expression of IL-33 and TREM2, increased by seven and ten times respectively. improved AD symptoms and delayed cognitive decline.
The doctor Babak Baban, immunologist and associate dean for research at the Augusta Georgia Dental College of Georgia, finally explained in a press release that the CBD ha reduced protein levels IL-6, which is associated with the high levels of inflammation found in Alzheimer's.
I next steps In conclusion, the researchers foresee the determination of optimal doses, the administration of CBD in the early stages of the disease process and the transition to potential clinical studies.
